Quinidine Gluconate (Eli Lilly and Company)
Welcome to the PulseAid listing for the Quinidine Gluconate drug offered from Eli Lilly and Company. This Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Eli Lilly and Company |
NON-PROPRIETARY NAME: | Quinidine Gluconate |
SUBSTANCE NAME: | QUINIDINE GLUCONATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1950-07-12 |
END MARKETING DATE: | 0000-00-00 |
Quinidine Gluconate HUMAN PRESCRIPTION DRUG Details:
Item Description | Quinidine Gluconate from Eli Lilly and Company |
LABELER NAME: | Eli Lilly and Company |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 80(mg/mL) |
START MARKETING DATE: | 1950-07-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0002-1407_14757f9d-f641-4836-acf3-229265588d1d |
PRODUCT NDC: | 0002-1407 |
APPLICATION NUMBER: | NDA007529 |
Other QUINIDINE GLUCONATE Pharmaceutical Manufacturers / Labelers: